Amy W Schulman - Net Worth and Insider Trading

Amy W Schulman Net Worth

The estimated net worth of Amy W Schulman is at least $7 Million dollars as of 2024-04-29. Amy W Schulman is the Executive Vice President of Pfizer Inc and owns about 227,003 shares of Pfizer Inc (PFE) stock worth over $6 Million. Amy W Schulman is the Director of Zoetis Inc and owns about 5,000 shares of Zoetis Inc (ZTS) stock worth over $799,800. Amy W Schulman is also the Director of Cyclerion Therapeutics Inc and owns about 31,681 shares of Cyclerion Therapeutics Inc (CYCN) stock worth over $97,577. Besides these, Amy W Schulman also holds SQZ Biotechnologies Co (SQZB) . Details can be seen in Amy W Schulman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Amy W Schulman has not made any transactions after 2021-12-13 and currently still holds the listed stock(s).

Transaction Summary of Amy W Schulman

To

Amy W Schulman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Amy W Schulman owns 13 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Cyclerion Therapeutics Inc (CYCN) , and Hudson Executive Investment Corp (HECCU) among others .

Click here to see the complete history of Amy W Schulman’s form 4 insider trades.

Insider Ownership Summary of Amy W Schulman

Ticker Comapny Transaction Date Type of Owner
ALNY Alnylam Pharmaceuticals Inc 2015-06-01 director
CYCN Cyclerion Therapeutics Inc 2019-04-08 director
HECCU Hudson Executive Investment Corp 2020-06-08 director
IRWD Ironwood Pharmaceuticals Inc 2017-01-01 director
XFOR X4 Pharmaceuticals Inc 2017-11-15 director
BUFF Blue Buffalo Pet Products Inc 2018-04-24 director
BINDQ DNIB Unwind Inc 2015-06-09 director
PFE Pfizer Inc 2013-05-15 Senior Vice President
ZTS Zoetis Inc 2013-02-06 director
SQZB SQZ Biotechnologies Co 2021-12-13 director & 10 percent owner
TALK Talkspace Inc 2020-06-08 director
HCIIU Hudson Executive Investment Corp II 2021-01-25 director
HCII Hudson Executive Investment Corp II 2021-01-25 director

Amy W Schulman Latest Holdings Summary

Amy W Schulman currently owns a total of 4 stocks. Among these stocks, Amy W Schulman owns 227,003 shares of Pfizer Inc (PFE) as of May 15, 2013, with a value of $6 Million and a weighting of 86.43%. Amy W Schulman owns 5,000 shares of Zoetis Inc (ZTS) as of February 6, 2013, with a value of $799,800 and a weighting of 11.91%. Amy W Schulman also owns 31,681 shares of Cyclerion Therapeutics Inc (CYCN) as of April 8, 2019, with a value of $97,577 and a weighting of 1.45%. The other 1 stocks SQZ Biotechnologies Co (SQZB) have a combined weighting of 0.21% among all his current holdings.

Latest Holdings of Amy W Schulman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PFE Pfizer Inc 2013-05-15 227,003 25.58 5,806,737
ZTS Zoetis Inc 2013-02-06 5,000 159.96 799,800
CYCN Cyclerion Therapeutics Inc 2019-04-08 31,681 3.08 97,577
SQZB SQZ Biotechnologies Co 2021-12-13 301,955 0.05 14,041

Holding Weightings of Amy W Schulman


Amy W Schulman Form 4 Trading Tracker

According to the SEC Form 4 filings, Amy W Schulman has made a total of 0 transactions in Pfizer Inc (PFE) over the past 5 years. The most-recent trade in Pfizer Inc is the sale of 70,000 shares on May 15, 2013, which brought Amy W Schulman around $2 Million.

According to the SEC Form 4 filings, Amy W Schulman has made a total of 0 transactions in Zoetis Inc (ZTS) over the past 5 years. The most-recent trade in Zoetis Inc is the acquisition of 5,000 shares on February 6, 2013, which cost Amy W Schulman around $130,000.

According to the SEC Form 4 filings, Amy W Schulman has made a total of 0 transactions in Cyclerion Therapeutics Inc (CYCN) over the past 5 years. The most-recent trade in Cyclerion Therapeutics Inc is the acquisition of 31,306 shares on April 8, 2019, which cost Amy W Schulman around $10 Million.

More details on Amy W Schulman's insider transactions can be found in the Insider Trading History of Amy W Schulman table.

Insider Trading History of Amy W Schulman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Amy W Schulman Trading Performance

GuruFocus tracks the stock performance after each of Amy W Schulman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amy W Schulman is -6.89%. GuruFocus also compares Amy W Schulman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amy W Schulman within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Amy W Schulman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Amy W Schulman

Average Return

-47.92%

Average return per transaction

Outperforming Transactions

0%

0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.58 -6.89 -36 -47.92 -48.18 -45.18
Relative Return to S&P 500(%) 9.08 -10.26 -40.23 -57.09 -58.43 -55.91

Amy W Schulman Ownership Network

Ownership Network List of Amy W Schulman

No Data

Ownership Network Relation of Amy W Schulman


Amy W Schulman Owned Company Details

What does Alnylam Pharmaceuticals Inc do?

Who are the key executives at Alnylam Pharmaceuticals Inc?

Amy W Schulman is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Tolga Tanguler , CMO & EVP Dev & Med Affairs Pushkal Garg , and EVP & CLO & Secretary Indrani Lall Franchini .

Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary

Over the past 18 months, Amy W Schulman made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 30,567 shares made by Pushkal Garg , a net sale of 7,095 shares made by Indrani Lall Franchini , and a net sale of 14,604 shares made by Yvonne Greenstreet .

In summary, during the past 3 months, insiders sold 36,501 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 36,501 shares. During the past 18 months, 159,676 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 159,676 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alnylam Pharmaceuticals Inc Insider Transactions

No Available Data

Amy W Schulman Mailing Address

Above is the net worth, insider trading, and ownership report for Amy W Schulman. You might contact Amy W Schulman via mailing address: Pfizer Inc. Attn: Corporate Secretary, 235 East 42nd Street, New York Ny 10017.

Discussions on Amy W Schulman

No discussions yet.